To test whether pancreatic hormonal changes that occur during exercise are necessary for the postexercise enhancement of insulin-stimulated net hepatic glucose uptake, chronically catheterized dogs were exercised on a treadmill or rested for 150 min. At the onset of exercise, somatostatin was infused into a peripheral vein, and insulin and glucagon were infused in the portal vein to maintain basal levels (EX-Basal) or simulate the response to exercise (EX-Sim). Glucose was infused as needed to maintain euglycemia during exercise. After exercise or rest, somatostatin infusion was continued in exercised dogs and initiated in dogs that had remained sedentary. In addition, basal glucagon, glucose, and insulin were infused in the portal vein for 150 min to create a hyperinsulinemic-hyperglycemic clamp in EXBasal, EX-Sim, and sedentary dogs. Steady-state measurements were made during the final 50 min of the clamp. During exercise, net hepatic glucose output (mg ⅐ kg ؊1 ⅐ min ؊1 ) rose in EX-Sim (7.6 ؎ 2.8) but not EX-Basal (1.9 ؎ 0.3) dogs. During the hyperinsulinemichyperglycemic clamp that followed either exercise or rest, net hepatic glucose uptake (mg ⅐ kg ؊1 ⅐ min ؊1 ) was elevated in both EX-Basal (4.0 ؎ 0.7) and EX-Sim (4.6 ؎ 0.5) dogs compared with sedentary dogs (2.0 ؎ 0.3). Despite this elevation in net hepatic glucose uptake after exercise, glucose incorporation into hepatic glycogen, determined using [3-3 H]glucose, was not different in EX-Basal and sedentary dogs, but was 50 ؎ 30% greater in EX-Sim dogs. Exercise-induced changes in insulin and glucagon, and consequent glycogen depletion, are not required for the increase in net hepatic glucose uptake after exercise but result in a greater fraction of the glucose consumed by the liver being directed to glycogen. Diabetes 53:3041-3047, 2004 S ustained exercise has been shown to improve net hepatic glucose uptake (NHGU) and enhance hepatic glycogen synthesis (1,2). Our previous work has shown that the enhanced NHGU during a glucose load after exercise is due to improvements in hepatic insulin action (2). Although exercise clearly improves insulin-stimulated NHGU, it is not known what part of the exercise response leads to the postexercise enhancement in NHGU.
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During exercise, hepatic glycogen stores are mobilized and gluconeogenesis is accelerated to help meet the increased energy demands of working muscle. Previous work in the dog has shown that the changes in insulin and glucagon during exercise are essential to the regulation of hepatic glucose output during exercise (3) , and preventing the fall in insulin (4) and the rise in glucagon (5) attenuates the glycogenolytic and gluconeogenic responses seen during exercise. In particular, the depletion of liver glycogen is likely to have persistent effects.
Interestingly, work in hepatocytes has shown that hepatic glycogen synthesis is inversely proportional to hepatic glycogen content, suggesting that hepatic glycogen may play a role in the regulation of its own synthesis (6) . Additionally sustained fasting, a condition that depletes hepatic glycogen, causes improved NHGU during a glucose load (7) . Considering these findings, and the importance of exercise-induced changes in insulin and glucagon to the increase in hepatic glucose production, it is possible that these hormone changes during exercise can affect the postexercise handling of a glucose load. To this end, we hypothesized that preventing exercise-induced changes in insulin and glucagon, and therefore hepatic glycogen depletion, would attenuate the postexercise increases in NHGU and hepatic glycogen synthesis during a subsequent glucose load. standard food (34% protein, 14.5% fat, 46% carbohydrate, and 5.5% fiber based on dry weight).
At least 16 days before an experiment, a laparotomy was performed under general anesthesia for the insertion of infusion and sampling catheters as well as transonic flow probes. Infusion catheters were inserted into the inferior vena cava for the infusion of somatostatin (SRIF), glucose, [3- 3 H]glucose, and L-[
14 C]glucose. Infusion catheters were also inserted into the splenic and jejunal veins and fed forward into the portal vein for the infusion of glucose, insulin, glucagon, and L-[ 14 C]glucose. Sampling catheters were inserted into the portal vein and hepatic vein as well as the femoral artery. After insertion, catheters were filled with saline containing heparin and knotted at the free ends. Sections of the hepatic artery and portal vein upstream of the liver were cleared of tissue and fitted with Transonic flow probes for the measurement of blood flow. Flow probe leads and the knotted catheter ends were placed in a subcutaneous pocket made in the abdominal region. The femoral artery catheter was placed in a subcutaneous pocket made in the inguinal region. Animals that met the experiment inclusion criteria (normal stool, white blood cell count Ͻ18,000 [8] , and a hematocrit Ͼ0.35) were fasted 18 h before an experiment. Experimental protocol. After the 18-h fast, the catheters and flow probes were freed from the subcutaneous pockets using 2-cm incisions after applying a local anesthesia (2% lidocaine). Catheters were aspirated with saline. Saline was infused into the arterial sampling catheter for the duration of the experiment. The experimental protocol is shown in Fig. 1 . Animals were subjected to 150 min (t ϭ Ϫ190 to Ϫ40 min; denoted as the exercise period) of moderate-intensity treadmill exercise (4 mph, 12% grade). At the onset of exercise (Ϫ190 min), SRIF (0.8 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ) was infused peripherally to inhibit pancreatic hormone secretion. During exercise, insulin and glucagon were infused into the portal vein to either replace basal levels of both hormones (0.2 mU ⅐ kg Ϫ1 ⅐ min Ϫ1 and 0.5 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 , respectively; n ϭ 7) or simulate the fall in insulin and rise in glucagon that occurs during exercise (n ϭ 7). The simulated infusion rates involved changes in the rates of insulin and glucagon infusion over the course of exercise. At t ϭ Ϫ190 min, insulin was infused at 0.2 mU ⅐ kg Ϫ1 ⅐ min Ϫ1 and was reduced to 0.15 mU ⅐ kg
Ϫ1
⅐ min Ϫ1 at t ϭ Ϫ185, where it remained for the duration of exercise. Glucagon was infused at 1.0 ng ⅐ kg
Ϫ1 from t ϭ Ϫ100 to Ϫ40 min, and 0.5 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 from Ϫ40 to 0 min. Variable peripheral glucose was infused as needed to maintain euglycemia. At t ϭ Ϫ120 min, peripheral infusions of indocyanine green (ICG), [3- 3 H]glucose, and L-[
14 C]glucose were initiated. ICG was infused as an alternative means to calculate splanchnic blood flow if the Transonic flow probes failed during a given experiment. ICG-determined blood flow was required in three experiments. [3- 3 H]glucose was used to calculate net hepatic glycogen synthesized as described in Calculations. The ICG and [3- 3 H]glucose infusions continued for the duration of the experiment. At the end of exercise (t ϭ Ϫ40 min), dogs were transferred to a Pavlov harness and insulin and glucagon hormone infusions were returned to basal levels. From t ϭ 0 to 150 min (noted as the experimental period in Fig. 1) , glucagon, insulin, and glucose were infused into the portal vein. Glucagon was infused (0.5 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 ) to maintain basal circulating levels. Insulin was infused (1.2 mU ⅐ kg Ϫ1 ⅐ min Ϫ1 ) to establish a mild physiological hyperinsulinemia, and glucose was infused to induce hyperglycemia. At t ϭ 0 min, the peripheral L-[
14 C]glucose infusion was terminated. L-[
14 C]glucose was added to the portal glucose infusion to maintain the rate of peripheral L-[
14 C]glucose infusion seen from t ϭ Ϫ120 to 0 min. Because L-[
14 C]glucose is not taken up by the liver, the measurement of circulating 14 C radioactivity during the portal vein infusion serves as an indicator of the efficiency with which glucose infused into the portal vein mixes with portal vein blood. The determination of mixing is further described in Calculations. After these infusions were initiated, 100 min was allowed for the establishment of steady-state conditions (i.e., constant arterial glucose concentrations). Arterial, portal vein, and hepatic vein blood samples were taken during exercise for the assessment of hepatic glucose balance and circulating hormone levels. Blood samples were also taken in 15-min intervals during the baseline period (t ϭ Ϫ30 to 0 min) and every 10 min during the steady-state period (t ϭ 100 -150 min) for the assessment of substrate concentrations, circulating hormones, and radioactivity. Blood samples were FIG. 1. Experimental protocol. Dogs were submitted to 150 min of treadmill exercise. Hormones were either clamped at basal levels (EX-Basal; n ‫؍‬ 7) or simulated the rise in glucagon and fall in insulin (EX-Sim; n ‫؍‬ 7) during exercise. The simulated infusion rates involved changes in the rates of insulin and glucagon infusion over the course of exercise. At t ‫؍‬ ؊190 min, insulin was infused at 0.2 mU ⅐ kg ؊1 ⅐ min ؊1 and was reduced to 0.15 mU ⅐ kg ؊1 ⅐ min ؊1 at t ‫؍‬ ؊185, where it remained for the duration of exercise. Glucagon was infused at 1.0 ng ⅐ kg ؊1 ⅐ min ؊1 from t ‫؍‬ ؊190 to ؊180 min, 1.1 ng ⅐ kg ؊1 ⅐ min ؊1 from t ‫؍‬ ؊180 to ؊170 min, 1.2 ng ⅐ kg ؊1 ⅐ min ؊1 from t ‫؍‬ ؊170 to ؊160 min, 1.3 ng ⅐ kg ؊1 ⅐ min ؊1 from t ‫؍‬ ؊160 to ؊100 min, 1.75 ng ⅐ kg ؊1 ⅐ min ؊1 from t ‫؍‬ ؊100 to ؊40 min, and 0.5 ng ⅐ kg ؊1 ⅐ min ؊1 from ؊40 to 0 min. A sedentary group, six of which were previously published (2), was rested for an equivalent period of time as the exercise bout. After exercise or rest, all dogs were subjected to the hyperinsulinemic-hyperglycemic clamp.
taken at 50-min intervals during the exercise period. Portal vein and hepatic artery blood flow was recorded when blood samples were taken. After the final blood sample, dogs were killed with sodium pentobarbital. Liver biopsies were quickly frozen in liquid nitrogen. After biopsies were collected, catheter and flow probe placement was confirmed.
Data from exercised dogs were compared with a sedentary control group (n ϭ 7, 6 of which have been previously published [2] ). The sedentary dogs were studied using the identical protocol as exercised dogs except they remained sedentary in the harness for a duration equivalent to the exercise period. Because animals were not exercised, SRIF was not infused until t ϭ 0 min. Plasma and blood sample analysis. Plasma glucose concentrations were determined by the glucose oxidase method using a Beckman Glucose Analyzer II (Beckman Instruments, Fullerton, CA) on the day of the experiment. Plasma samples, which where not immediately analyzed, were stored at Ϫ70°C for later analysis. Plasma insulin, glucagon, and cortisol concentrations were determined as described previously by radioimmunoassay (9,10). All antibodies and human standards were obtained from Linco Research (St. Charles, MO). Plasma epinephrine and norepinephrine concentrations were determined by high-performance liquid chromatography as previously described (11) . Plasma free fatty acid concentrations were determined by enzymatic analysis using a kit from Wako Chemicals (Richmond, VA).
For the determination of radioactivity, blood samples were deproteinized with barium hydroxide and zinc sulfate. After centrifugation (3,000g, 30 min, 4°C), the supernatant was dried and reconstituted in 1 ml water and 10 ml scintillent (Ultima Gold; Packard, Meriden, CT). Radioactivity was determined using a Packard TRI-CARB 2900TR liquid scintillation counter. Blood concentrations of glucose, lactate, glycerol, and alanine were determined by enzymatic analysis after deproteinization (1 ml blood with 3 ml of 4% perchloric acid). Liver sample analysis. Liver glycogen was determined as previously described by Chan and Exton (12) . For the determination of liver glucose-6-phosphate and fructose-6-phosphate, liver samples were homogenized in 8% perchloric acid, and the supernatant was collected after centrifugation (3,000g, 30 min, 4°C). Liver glycogen (after hydrolysis to glucose by amyloglucosidase), glucose-6-phosphate, and fructose-6-phosphate were determined by enzymatic analysis on a Technicon Auto-Analyzer (13 For a given experiment to be included herein, at least half of the time points during the experimental period had to meet the mixing criteria. Based on this inclusion criteria, all data from two dogs were excluded. These dogs are not included in the subject number.
The net amount of glycogen synthesized during the experiment was calculated as the amount of radioactivity from [3- 3 H]glucose per milligram tissue divided by the inflowing specific activity. The specific activity of inflowing glucose was calculated as (SA A ϫ HAF ϩ SA P ϫ PVF)/(PVF ϩ HAF), where SA A and SA P are the specific activities of glucose in the artery and portal vein. The use of [3- 3 H]glucose for assessment of glycogen synthesis only accounts for glucose incorporated into glycogen via the direct pathway (glucose 3 UDP-glucose 3 glycogen) and assumes that minimal [3- 3 H]glucose is stored as glycogen before t ϭ 0 min (15) . Statistical analysis. Statistical analyses were performed using Sigma Plot 8.0 software. Two-way ANOVA and two-way repeated-measures ANOVA were used for comparisons between groups when appropriate. P values Ͻ0.05 were considered significant.
RESULTS
Arterial plasma insulin, glucagon, NHGO, and arterial blood glucose during exercise. During the exercise period, arterial plasma insulin levels ( Fig. 2A) were maintained at basal concentrations in the group that received basal hormone infusions during exercise (EX-Basal) and showed a small fall in the group that received simulated hormone infusions during exercise (EX-Sim) (P Ͼ 0.05, NS). Arterial plasma glucagon was maintained at basal levels in EX-Basal, whereas EX-Sim had a marked increase over the course of exercise (Fig. 2B) . It is impossible to precisely recreate the normal response of the endocrine pancreas. However, the simulated hormone infusion in EX-Sim resulted in hepatic glucose output consistent with a normal hormonal exercise response. As a result of the basal hormone clamp, NHGO did not change from values seen before exercise (t ϭ Ϫ190 min; Fig. 3A) . However, in EX-Sim, NHGO was increased approximately twofold during exercise. In both exercised groups, euglycemia was maintained with a variable peripheral glucose infusion (Fig. 3B) . Over the first 90 min of the exercise period, the glucose infusion rate (GIR) required to maintain euglycemia was 2.7 Ϯ 0.4 in EX-Basal and 0.5 Ϯ 0.5 in EX-Sim. It should be noted however that peripheral glucose was only required in one dog in EX-Sim during the first 90 min of exercise. Over the final 60 min of exercise, the GIR required for euglycemia was 5.9 Ϯ 0.6 in EX-Basal and 2.0 Ϯ 0.7 in EX-Sim. Arterial plasma hormones. Hormone infusions were either returned to (EX-Sim) or maintained at (EX-Basal) basal levels after exercise. During the baseline period after exercise, arterial plasma insulin (Fig. 4A ) was decreased in EX-Basal and EX-Sim compared with the sedentary group. During the experimental period, arterial plasma insulin rose ϳ2.5-fold in all groups. Arterial plasma glucagon, epinephrine, and norepinephrine concentrations during the baseline period after exercise or rest were similar in all groups and were not different during the experimental period (Table 1) . Arterial plasma cortisol concentrations were elevated during the baseline period after exercise in the EX-Sim group but not EX-Basal group compared with the sedentary control group. During the experimental period, cortisol levels returned to basal and were similar to the sedentary group. Arterial blood glucose, HGL, and GIR. During the baseline period, arterial blood glucose levels (Fig. 4B) and HGL (Fig. 4C) were similar in sedentary and exercised groups. During the experimental period, arterial blood glucose and HGL increased by ϳ80% in all groups. The GIR required to maintain the hyperglycemic clamp was significantly higher in both the EX-Basal (22.1 Ϯ 1.8 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 ) and EX-Sim (22.6 Ϯ 1.6 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 ) groups compared with the sedentary group (10.8 Ϯ 1.3 mg ⅐ kg from output, seen during the baseline period, to net uptake of glucose (Fig. 5A) . NHGU was significantly increased in both EX-Basal (4.0 Ϯ 0.7 mg ⅐ kg Ϫ1 ⅐ min
Ϫ1
) and EX-Sim (4.6 Ϯ 0.5 mg ⅐ kg Ϫ1 ⅐ min
) dogs compared with sedentary dogs (2.0 Ϯ 0.3 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 ). Net hepatic glucose fractional extraction showed a pattern identical to that of NHGU (Fig. 5B) . Arterial lactate, nonesterified fatty acids, glycerol, alanine concentrations, and NHB. Arterial concentrations of lactate, alanine, glycerol, and nonesterified fatty acids (NEFAs) are shown in Table 2 . Arterial lactate and alanine levels were not significantly different between groups or periods. Arterial glycerol and NEFA levels were similar between groups during the baseline period. During the experimental period, arterial glycerol and NEFA levels fell to a similar extent in all groups. Neither NHB of lactate or alanine was significantly different between groups (Table 3). NHB of glycerol and NEFAs were similar between groups during the baseline and experimental periods. During the experimental period, the net uptake of glycerol and NEFAs was reduced to similar rates in all groups because of a fall in their circulating concentrations. Liver glycogen synthesis, glucose-6-phosphate, fructose-6-phosphate, and glycogen synthase/phosphorylase activity ratios. Liver glycogen synthesis was similar in the EX-Basal and sedentary groups but was increased by ϳ50% in the EX-Sim group compared with the sedentary group (Fig. 6 ). Glucose-6-phosphate levels were increased in both EX-Basal and EX-Sim dogs compared with the sedentary group (Table 4) . Fructose-6-phosphate levels were similar in the EX-Basal and sedentary groups but showed a significant reduction in the EX-Sim group. The glycogen synthase activity ratios were similar in all groups. However, the activity ratio of glycogen phosphorylase was significantly reduced in the EX-Sim group compared with the sedentary group. 
Data are means Ϯ SE. *P Յ 0.05 vs. sedentary and EX-Basal baseline. 
Data are means Ϯ SE. *P Յ 0.05 vs. baseline.
DISCUSSION
When the exercise-induced changes in insulin and glucagon were fixed at basal levels, NHGO remained the same as that seen before the start of exercise and was comparable to baseline NHGO in sedentary dogs. The glucose requirements of working muscle were met with a peripheral glucose infusion when pancreatic hormones were clamped at basal levels. In the exercise group that received the simulated infusion, ϳ25 g glucose was mobilized from the liver (estimated by multiplying the NHGO by the duration of the exercise bout and the dog weight) over the course of exercise. In the exercise group that received the basal pancreatic hormone infusion, ϳ8 g was mobilized from the liver over the course of exercise. The mobilization of glucose in the basal pancreatic hormone group was equal to that seen in dogs that remained sedentary. The levels of NHGO seen in EX-Sim dogs (ϳ8 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 ) were identical to NHGO in previous work where artificial hormonal manipulation was not used in dogs exercising at a similar intensity (4, 5, 16) , and the increment in NHGO from basal was consistent with increases in the rate of whole-body glucose appearance previously seen (15, (17) (18) (19) . The primary source of the increased glucose production during 150 min of exercise is hepatic glycogenolysis in the 18-h fasted dog (20) . During the experimental period, the GIR required to maintain the glucose clamp was elevated to a similar rate in both exercise groups regardless of the hormonal manipulation performed during the exercise bout. This increase in the GIR in both exercise groups indicates that the whole-body insulin sensitization that normally occurs after exercise is intact, even when insulin and glucagon do not change during exercise. Under both exercise conditions as well as the sedentary condition, NHGU accounted for ϳ20% of whole-body glucose uptake during the hyperinsulinemichyperglycemic clamp.
The work presented here shows that insulin-stimulated NHGU is increased after exercise, even when the rise in glucagon and fall in insulin are attenuated during the exercise period. Although NHGU increased in both exercise groups, preventing the hormone changes during exercise attenuated the increase in glycogen synthesis after exercise. Previous work has shown that exercise enhances insulin-stimulated NHGU, but the enhancement in glycogen synthesis after exercise is not due to an enhancement in insulin stimulation (2) . These previous findings indicate that other control elements, in addition to insulin, are responsible for the postexercise enhancement in glycogen synthesis.
A key regulatory element of glycogen synthesis is glucose-6-phosphate (21) . The phosphorylation of glucose by glucokinase is a key regulatory step in hepatic glycogen synthesis, since it provides substrate for the process but also allosterically increases glycogen synthase activity and inhibits glycogen phosphorylase activity (22) . In this experiment, glucose-6-phosphate increased in both exercise groups. However, net glycogen synthesis was more pronounced in the exercise group that received the simulated pancreatic hormone infusion. The increased hepatic glycogen synthesis in EX-Sim occurred with a fall in fructose-6-phosphate compared with both EX-Basal and the sedentary group. This fall in fructose-6-phosphate could possibly have been a consequence of enhanced flux of glucose to hepatic glycogen assuming glycolysis was reduced reciprocally. Considering the comparable NHGU and glucose-6-phosphate levels seen in both exercise groups, it is likely that regulatory processes other than glucose and glucose-6-phosphate are responsible for the increased net hepatic glycogen synthesis seen in the exercise group that received the simulated pancreatic hormone infusion.
Previous work in cultured hepatocytes has shown that glycogen synthesis is attenuated in the presence of elevated hepatic glycogen stores (6) . This finding indicates that hepatic glycogen synthesis may be in part autoregulatory. Fasting for 42 h in the dog results in the depletion of hepatic glycogen stores similar to that seen with prolonged exercise. The delivery of a glucose load following such a fast results in increased net hepatic glycogen synthesis (7) . In addition to these findings, histochemical analysis of rat hepatocytes has shown that elevations in glycogen stores within the cell inhibit the normal translocation of glycogen synthase to the cell periphery in response to glucose (23) . This work also showed that chemical activation of glycogen synthase is not sufficient to cause translocation of the enzyme, thus indicating that translocation and activation may have distinct methods of regulation.
In addition to glycogen playing a role in the regulation of its own synthesis, glycogen phosphorylase is also a key regulator of the synthesis and breakdown of hepatic 
TABLE 4
Liver glucose-6-phosphate levels, fructose-6-phosphate levels, and glycogen synthase and phosphorylase activity ratios
EX-Basal EX-Sim Sedentary
Glucose-6-phosphate (mg/100 g liver) 9.9 Ϯ 1. glycogen. Metabolic control analysis has shown that glycogen phosphorylase is a strong negative regulator of net glycogen synthesis (24) . Consistent with this finding is the reduction in phosphorylase activity seen in exercised dogs that received the simulated pancreatic hormone infusion. The reduction in phosphorylase activity was not seen in the exercise group that received the basal pancreatic hormone infusion. Another potential mechanism for the enhancement of hepatic glycogen synthesis is prolonged exposure to elevated cortisol levels. The work presented here shows that after exercise, the group that received the simulated hormone infusion had a marked increase in arterial plasma cortisol, whereas the dog that received basal insulin and glucagon did not exhibit increased cortisol. This is consistent with previous work in the dog that showed the increase in cortisol during exercise requires the normal increase in glucagon (4). These separate observations suggest that glucagon or the metabolic effects of glucagon are involved in the release or clearance of cortisol. Chronic exposure to cortisol (5 days) has been shown to markedly increase glycogen storage in the conscious dog (25) .
In conclusion, the pancreatic hormone changes that occur during exercise and the consequent mobilization of hepatic glycogen are not responsible for the postexercise enhancement in insulin-stimulated NHGU, but are critical to the determination of the fate of the additional glucose taken up by the liver. Thus, the pathways for NHGU and glycogen synthesis are regulated differently after exercise.
